# THROTTLE

In House datasets

| Partners       | Country | Short Description | Type of Data   | #Patients      | Availability   |
|      :---:     |  :---:  |      :---:       |      :---:     |      :---:     |      :---:     |
|KI              | SE | NGS and methylation can be exploited for neoantigen designation    | WGS, WES, RNAseq, targeted panels. Full clinical annotation. | n > 100 | In House |
|IDIBAPS| ES | NGS and methylation can be exploited for neoantigen designation    | WGS, WES, RNAseq, ChIPseq, ATACseq, methylation, microarrays. Full clinical annotation | n > 500 | In House, PMID: 35927489, PMID: 26200345, PMID: 34079956, PMID: 29785028 |
